Home LiteratureArticle Details
PMID: 9371595 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.

Journal of virology ·Vol. 71 ·No. 12 ·1997-12-00 ·Pages 9358-65

Bouyac M, Courcoul M, Bertoia G, Baudat Y, Gabuzda D, Blanc D, Chazal N, Boulanger P, Sire J, Vigne R, Spire B

Abstract

The Vif protein of human immunodeficiency virus type 1 is required for productive replication in peripheral blood lymphocytes. Previous reports suggest that vif-deleted viruses are limited in replication because of a defect in the late steps of the virus life cycle. One of the remaining questions is to determine whether the functional role of Vif involves a specific interaction with virus core proteins. In this study, we demonstrate a direct interaction between Vif and the Pr55Gag precursor in vitro as well as in infected cells. No interaction is observed between Vif and the mature capsid protein. The Pr55Gag-Vif interaction is detected (i) in the glutathione S-transferase system, with in vitro-translated proteins demonstrating a critical role of the NC p7 domain of the Gag precursor; (ii) with proteins expressed in infected cells; and (iii) by coimmunoprecipitation experiments. Deletion of the C-terminal 22 amino acids of Vif abolishes its interaction with the Pr55Gag precursor. Furthermore, point mutations in the C-terminal domain of Vif which have been previously shown to abolish virus infectivity and binding to cell membranes dramatically decrease the Gag-Vif interaction. These results suggest that the interaction between Vif and the pr55Gag precursor is a critical determinant of Vif function.

MeSH Terms
Amino Acid Sequence Binding Sites Gene Products, gag/metabolism Gene Products, vif/genetics,metabolism Glutathione Transferase/genetics HIV-1/metabolism HeLa Cells Humans Molecular Sequence Data Protein Biosynthesis Protein Precursors/metabolism Recombinant Fusion Proteins/genetics,metabolism vif Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, gag Gene Products, vif Protein Precursors Recombinant Fusion Proteins p55 gag precursor protein, Human immunodeficiency virus 1 vif Gene Products, Human Immunodeficiency Virus Glutathione Transferase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Bouyac M
INSERM U372, Marseille, France.
Courcoul M
Bertoia G
Baudat Y
Gabuzda D
Blanc D
Chazal N
Boulanger P
Sire J
Vigne R
Spire B
References (48)
48 references, click to expand
  1. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.
    J Virol. 1993 Mar;67(3):1663-6 PMID: 8437236
  2. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.
    J Virol. 1997 Jul;71(7):5259-67 PMID: 9188594
  3. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
    Cell. 1993 Jun 18;73(6):1067-78 PMID: 8513493
  4. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    J Virol. 1993 Aug;67(8):4945-55 PMID: 8331734
  5. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
    J Virol. 1993 Oct;67(10):6322-6 PMID: 8371360
  6. Subcellular localization of the Vif protein of human immunodeficiency virus type 1.
    J Virol. 1994 Feb;68(2):704-12 PMID: 8289374
  7. Role of vif during packing of the core of HIV-1.
    Virology. 1994 Jun;201(2):349-55 PMID: 8184544
  8. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages.
    J Acquir Immune Defic Syndr. 1994 Sep;7(9):908-15 PMID: 7519673
  9. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic.
    J Biol Chem. 1994 Dec 2;269(48):30073-6 PMID: 7982906
  10. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    J Virol. 1995 Jan;69(1):365-75 PMID: 7983731
  11. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity.
    J Virol. 1995 Mar;69(3):1778-84 PMID: 7853517
  12. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    J Virol. 1995 Apr;69(4):2058-67 PMID: 7884851
  13. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
    J Virol. 1995 Apr;69(4):2068-74 PMID: 7884852
  14. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
    J Virol. 1995 Apr;69(4):2366-77 PMID: 7884882
  15. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.
    J Virol. 1995 Jul;69(7):4166-72 PMID: 7769676
  16. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses.
    J Virol. 1996 Feb;70(2):1213-7 PMID: 8551582
  17. The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro.
    Biochem Biophys Res Commun. 1996 Jan 5;218(1):352-5 PMID: 8573160
  18. Phosphorylation of Vif and its role in HIV-1 replication.
    J Biol Chem. 1996 Apr 26;271(17):10121-9 PMID: 8626571
  19. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
    Virology. 1996 Jun 1;220(1):208-12 PMID: 8659115
  20. Characterization of human immunodeficiency virus type 1 Vif particle incorporation.
    J Virol. 1996 Sep;70(9):6106-11 PMID: 8709234
  21. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.
    J Virol. 1996 Aug;70(8):5297-305 PMID: 8764040
  22. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity.
    J Virol. 1996 Oct;70(10):6701-8 PMID: 8794306
  23. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus).
    Biochem Biophys Res Commun. 1984 May 31;121(1):126-33 PMID: 6203528
  24. Nucleotide sequence of the AIDS virus, LAV.
    Cell. 1985 Jan;40(1):9-17 PMID: 2981635
  25. A molecular clone of HTLV-III with biological activity.
    Nature. 1985 Jul 18-24;316(6025):262-5 PMID: 2410792
  26. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.
    Science. 1986 Mar 28;231(4745):1546-9 PMID: 3006243
  27. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  28. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus.
    Gene. 1989 Sep 30;81(2):275-84 PMID: 2806917
  29. Conservation of amino-acid sequence motifs in lentivirus Vif proteins.
    Virus Genes. 1992 Jan;6(1):95-102 PMID: 1312756
  30. HIV with multiple gene deletions as a live attenuated vaccine for AIDS.
    AIDS Res Hum Retroviruses. 1992 Mar;8(3):411-21 PMID: 1571200
  31. Cell-free transmission of Vif mutants of HIV-1.
    Virology. 1992 Sep;190(1):19-29 PMID: 1529528
  32. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    J Virol. 1992 Nov;66(11):6489-95 PMID: 1357189
  33. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.
    J Virol. 1995 Jul;69(7):4582-6 PMID: 7769728
  34. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
    Virology. 1995 Jun 20;210(1):202-5 PMID: 7793072
  35. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
    FEBS Lett. 1995 Aug 28;371(1):9-12 PMID: 7664891
  36. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.
    J Virol. 1995 Nov;69(11):7196-204 PMID: 7474141
  37. Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein NCp7 and its precursor NCp15 as detected by anti-NCp7 monoclonal antibodies.
    J Gen Virol. 1995 Oct;76 ( Pt 10):2457-66 PMID: 7595349
  38. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    J Virol. 1995 Dec;69(12):7630-8 PMID: 7494271
  39. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
    J Virol. 1996 Jan;70(1):494-507 PMID: 8523563
  40. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.
    J Virol. 1996 Feb;70(2):697-704 PMID: 8551605
  41. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    J Mol Biol. 1996 Sep 6;261(5):599-606 PMID: 8800208
  42. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication.
    Virology. 1996 Oct 1;224(1):246-55 PMID: 8862419
  43. Direct interaction between the envelope and matrix proteins of HIV-1.
    EMBO J. 1996 Nov 1;15(21):5783-8 PMID: 8918455
  44. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
    J Virol. 1996 Dec;70(12):8263-9 PMID: 8970945
  45. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
    J Virol. 1996 Dec;70(12):8645-52 PMID: 8970990
  46. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
    J Virol. 1996 Dec;70(12):8701-9 PMID: 8970997
  47. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
    J Virol. 1997 Mar;71(3):2473-7 PMID: 9032385
  48. Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle.
    Virology. 1993 Mar;193(1):186-92 PMID: 8438565
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1997-12-00
Pages
9358-65
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC230239
Subset
IM
Grants
NIAID NIH HHS · AI 36186 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]